MiLaboratories
@milaboratories.bsky.social
Creators of MiXCR & Platforma: the leading software for the analysis of NGS data for immune profiling. Posting updates on software releases and new features.
Platforma.bio
Platforma.bio
Want to accelerate your antibody discovery workflow?
Join our webinar to learn how to prioritize lead candidates faster.
You’ll discover how to track enrichment and liabilities, monitor clone dynamics over time, and predict developability to minimize risk
Register here: bit.ly/4p8157W
Join our webinar to learn how to prioritize lead candidates faster.
You’ll discover how to track enrichment and liabilities, monitor clone dynamics over time, and predict developability to minimize risk
Register here: bit.ly/4p8157W
November 13, 2025 at 3:36 PM
Want to accelerate your antibody discovery workflow?
Join our webinar to learn how to prioritize lead candidates faster.
You’ll discover how to track enrichment and liabilities, monitor clone dynamics over time, and predict developability to minimize risk
Register here: bit.ly/4p8157W
Join our webinar to learn how to prioritize lead candidates faster.
You’ll discover how to track enrichment and liabilities, monitor clone dynamics over time, and predict developability to minimize risk
Register here: bit.ly/4p8157W
This week, we kicked off our Platforma Pioneers academic tour at UCLA!
Our hands-on workshop on how to accelerate no-code NGS data analysis with Platforma was a blast.
A big thank you to everyone who joined us—we loved seeing your curiosity and creativity in action!
🚗 Next stops - USC and UCSD!
Our hands-on workshop on how to accelerate no-code NGS data analysis with Platforma was a blast.
A big thank you to everyone who joined us—we loved seeing your curiosity and creativity in action!
🚗 Next stops - USC and UCSD!
November 12, 2025 at 2:46 PM
This week, we kicked off our Platforma Pioneers academic tour at UCLA!
Our hands-on workshop on how to accelerate no-code NGS data analysis with Platforma was a blast.
A big thank you to everyone who joined us—we loved seeing your curiosity and creativity in action!
🚗 Next stops - USC and UCSD!
Our hands-on workshop on how to accelerate no-code NGS data analysis with Platforma was a blast.
A big thank you to everyone who joined us—we loved seeing your curiosity and creativity in action!
🚗 Next stops - USC and UCSD!
RNA-seq to monitor minimal residual disease (MRD) in multiple myeloma?
A recent Nature study found that RNA-seq achieved higher sensitivity and stronger prognostic value than DNA-seq for MRD.
We're proud that MiXCR was the key tool in this study.
Read more here: x.com/MiLaboratori...
A recent Nature study found that RNA-seq achieved higher sensitivity and stronger prognostic value than DNA-seq for MRD.
We're proud that MiXCR was the key tool in this study.
Read more here: x.com/MiLaboratori...
November 6, 2025 at 12:42 PM
RNA-seq to monitor minimal residual disease (MRD) in multiple myeloma?
A recent Nature study found that RNA-seq achieved higher sensitivity and stronger prognostic value than DNA-seq for MRD.
We're proud that MiXCR was the key tool in this study.
Read more here: x.com/MiLaboratori...
A recent Nature study found that RNA-seq achieved higher sensitivity and stronger prognostic value than DNA-seq for MRD.
We're proud that MiXCR was the key tool in this study.
Read more here: x.com/MiLaboratori...
We just wrapped up two impactful days at the Cell Symposium in Sitges, Spain with Cellecta! Was great to be face-to-face with researchers: live demos of Platforma, learning more about what others are working on, and sharing what our teams have been building.
Thanks to everyone who stopped by!
Thanks to everyone who stopped by!
November 5, 2025 at 2:50 PM
We just wrapped up two impactful days at the Cell Symposium in Sitges, Spain with Cellecta! Was great to be face-to-face with researchers: live demos of Platforma, learning more about what others are working on, and sharing what our teams have been building.
Thanks to everyone who stopped by!
Thanks to everyone who stopped by!
Proud to share a new study advancing non-invasive immune monitoring in cancer. Researchers found tumor-derived TCR clonotypes enriched in cfDNA and persisting >50 weeks in circulating T cells.
Proud that MiXCR powered large-scale TCR sequencing across tumor, blood, and cfDNA.
#cfDNA #TCRseq #TCR
Proud that MiXCR powered large-scale TCR sequencing across tumor, blood, and cfDNA.
#cfDNA #TCRseq #TCR
October 30, 2025 at 11:44 AM
Big news: we’ve launched an interactive demo on the Platforma website!
Choose your own scientific adventure:
🔹 Antibody Discovery
🔹 Differential Gene Expression
🔹 Single Cell Multiomics
🔹 TCR/BCR Repertoire Analysis
👉 Dive into the demo here: shorturl.at/7tkD4
#NGS #Multiomics #TCR #BCR
Choose your own scientific adventure:
🔹 Antibody Discovery
🔹 Differential Gene Expression
🔹 Single Cell Multiomics
🔹 TCR/BCR Repertoire Analysis
👉 Dive into the demo here: shorturl.at/7tkD4
#NGS #Multiomics #TCR #BCR
October 28, 2025 at 8:06 AM
Big news: we’ve launched an interactive demo on the Platforma website!
Choose your own scientific adventure:
🔹 Antibody Discovery
🔹 Differential Gene Expression
🔹 Single Cell Multiomics
🔹 TCR/BCR Repertoire Analysis
👉 Dive into the demo here: shorturl.at/7tkD4
#NGS #Multiomics #TCR #BCR
Choose your own scientific adventure:
🔹 Antibody Discovery
🔹 Differential Gene Expression
🔹 Single Cell Multiomics
🔹 TCR/BCR Repertoire Analysis
👉 Dive into the demo here: shorturl.at/7tkD4
#NGS #Multiomics #TCR #BCR
🔬 Empowering the next generation of scientists!
Today, our team hosted a hands-on Platforma workshop at the University of Navarra, where researchers explored Platforma's powerful functionalities hands on with real datasets.
Thanks to everyone who joined!
#bioinformatics #NGS
Today, our team hosted a hands-on Platforma workshop at the University of Navarra, where researchers explored Platforma's powerful functionalities hands on with real datasets.
Thanks to everyone who joined!
#bioinformatics #NGS
October 23, 2025 at 1:18 PM
🔬 Empowering the next generation of scientists!
Today, our team hosted a hands-on Platforma workshop at the University of Navarra, where researchers explored Platforma's powerful functionalities hands on with real datasets.
Thanks to everyone who joined!
#bioinformatics #NGS
Today, our team hosted a hands-on Platforma workshop at the University of Navarra, where researchers explored Platforma's powerful functionalities hands on with real datasets.
Thanks to everyone who joined!
#bioinformatics #NGS
Although we couldn’t make it to #ASHG2025, our partner Illumina presented a fantastic study on accurate full-length V(D)J clonotype detection using high-quality long reads on the MiSeq™ i100.
We’re especially proud that MiXCR was used to enable precise immune repertoire profiling.
We’re especially proud that MiXCR was used to enable precise immune repertoire profiling.
October 17, 2025 at 8:36 AM
Although we couldn’t make it to #ASHG2025, our partner Illumina presented a fantastic study on accurate full-length V(D)J clonotype detection using high-quality long reads on the MiSeq™ i100.
We’re especially proud that MiXCR was used to enable precise immune repertoire profiling.
We’re especially proud that MiXCR was used to enable precise immune repertoire profiling.
A major leap forward in treatment for Addison’s Disease!
In a new publication from bioRxiv, researchers pinpointed IFN-γ–producing self-reactive CD4+ T cells as the main drivers of autoimmune adrenalitis in a mouse model.
We're proud that MiXCR enabled analysis of TCR clonotypes from scRNAseq.
In a new publication from bioRxiv, researchers pinpointed IFN-γ–producing self-reactive CD4+ T cells as the main drivers of autoimmune adrenalitis in a mouse model.
We're proud that MiXCR enabled analysis of TCR clonotypes from scRNAseq.
October 16, 2025 at 11:12 AM
A major leap forward in treatment for Addison’s Disease!
In a new publication from bioRxiv, researchers pinpointed IFN-γ–producing self-reactive CD4+ T cells as the main drivers of autoimmune adrenalitis in a mouse model.
We're proud that MiXCR enabled analysis of TCR clonotypes from scRNAseq.
In a new publication from bioRxiv, researchers pinpointed IFN-γ–producing self-reactive CD4+ T cells as the main drivers of autoimmune adrenalitis in a mouse model.
We're proud that MiXCR enabled analysis of TCR clonotypes from scRNAseq.
Congratulations to Nobel Laureate Shimon Sakaguchi for his groundbreaking work on regulatory T cells! 🧬
We're proud to see our technology, MiXCR, supporting his lab’s research. In a recent study, MiXCR helped the team decode TCR repertoires.
Proud to support science that changes the world. 🌍
We're proud to see our technology, MiXCR, supporting his lab’s research. In a recent study, MiXCR helped the team decode TCR repertoires.
Proud to support science that changes the world. 🌍
October 8, 2025 at 8:25 AM
Congratulations to Nobel Laureate Shimon Sakaguchi for his groundbreaking work on regulatory T cells! 🧬
We're proud to see our technology, MiXCR, supporting his lab’s research. In a recent study, MiXCR helped the team decode TCR repertoires.
Proud to support science that changes the world. 🌍
We're proud to see our technology, MiXCR, supporting his lab’s research. In a recent study, MiXCR helped the team decode TCR repertoires.
Proud to support science that changes the world. 🌍
Biologists design brilliant experiments...then lose momentum waiting for results.
That’s why we built Platforma, to put the power of analysis directly into biologists’ hands.
🎥 Watch the demo to see how Platforma takes you from raw data to validated T-cell insights, without any coding.
That’s why we built Platforma, to put the power of analysis directly into biologists’ hands.
🎥 Watch the demo to see how Platforma takes you from raw data to validated T-cell insights, without any coding.
October 7, 2025 at 7:34 AM
Biologists design brilliant experiments...then lose momentum waiting for results.
That’s why we built Platforma, to put the power of analysis directly into biologists’ hands.
🎥 Watch the demo to see how Platforma takes you from raw data to validated T-cell insights, without any coding.
That’s why we built Platforma, to put the power of analysis directly into biologists’ hands.
🎥 Watch the demo to see how Platforma takes you from raw data to validated T-cell insights, without any coding.
October is Breast Cancer Awareness Month, a timely moment to spotlight new advances in how we understand and treat this disease. 🎗️
A recently study explores dynamic systemic immune responses in early-stage HR+ patients receiving chemotherapy + immunotherapy.
Read more here: shorturl.at/jOQkO
A recently study explores dynamic systemic immune responses in early-stage HR+ patients receiving chemotherapy + immunotherapy.
Read more here: shorturl.at/jOQkO
October 2, 2025 at 1:18 PM
October is Breast Cancer Awareness Month, a timely moment to spotlight new advances in how we understand and treat this disease. 🎗️
A recently study explores dynamic systemic immune responses in early-stage HR+ patients receiving chemotherapy + immunotherapy.
Read more here: shorturl.at/jOQkO
A recently study explores dynamic systemic immune responses in early-stage HR+ patients receiving chemotherapy + immunotherapy.
Read more here: shorturl.at/jOQkO
A new study from @ox.ac.uk shows why HR+ patients with lymph node metastasis fare worse:
- Weakened Defense: Tumor-reactive CD8 T cells are scarce, impairing cancer surveillance.
- Early-Stage Window: Early HR+ patients have a robust, diverse circulating CD8 TCR
More details: shorturl.at/0HP2l
- Weakened Defense: Tumor-reactive CD8 T cells are scarce, impairing cancer surveillance.
- Early-Stage Window: Early HR+ patients have a robust, diverse circulating CD8 TCR
More details: shorturl.at/0HP2l
September 25, 2025 at 1:17 PM
A new study from @ox.ac.uk shows why HR+ patients with lymph node metastasis fare worse:
- Weakened Defense: Tumor-reactive CD8 T cells are scarce, impairing cancer surveillance.
- Early-Stage Window: Early HR+ patients have a robust, diverse circulating CD8 TCR
More details: shorturl.at/0HP2l
- Weakened Defense: Tumor-reactive CD8 T cells are scarce, impairing cancer surveillance.
- Early-Stage Window: Early HR+ patients have a robust, diverse circulating CD8 TCR
More details: shorturl.at/0HP2l
We’re thrilled to team up with @yefis-immunology.bsky.social for our next webinar!
📅 October 7th, 16:00 CET
Platforma was built to make cutting-edge bioinformatics accessible to every scientist, so anyone can turn raw NGS into meaningful insights without coding.
🔗 Register here: shorturl.at/AQtCD
📅 October 7th, 16:00 CET
Platforma was built to make cutting-edge bioinformatics accessible to every scientist, so anyone can turn raw NGS into meaningful insights without coding.
🔗 Register here: shorturl.at/AQtCD
September 24, 2025 at 7:45 AM
We’re thrilled to team up with @yefis-immunology.bsky.social for our next webinar!
📅 October 7th, 16:00 CET
Platforma was built to make cutting-edge bioinformatics accessible to every scientist, so anyone can turn raw NGS into meaningful insights without coding.
🔗 Register here: shorturl.at/AQtCD
📅 October 7th, 16:00 CET
Platforma was built to make cutting-edge bioinformatics accessible to every scientist, so anyone can turn raw NGS into meaningful insights without coding.
🔗 Register here: shorturl.at/AQtCD
Last week we hosted a webinar with Kiel University and shared valuable insights on T-cell responses against EBV (Epstein–Barr Virus) and its implications for advancing research and therapeutic development.
Weren't able to attend?
🎥 Watch the recording here: www.youtube.com/watch?v=l2Q8...
Weren't able to attend?
🎥 Watch the recording here: www.youtube.com/watch?v=l2Q8...
September 23, 2025 at 12:20 PM
Last week we hosted a webinar with Kiel University and shared valuable insights on T-cell responses against EBV (Epstein–Barr Virus) and its implications for advancing research and therapeutic development.
Weren't able to attend?
🎥 Watch the recording here: www.youtube.com/watch?v=l2Q8...
Weren't able to attend?
🎥 Watch the recording here: www.youtube.com/watch?v=l2Q8...
Location, location, location.
Developing a multimodal framework, new research from @bcmhouston.bsky.social reveals that a T cell's location within a tumor is a major factor influencing its function.
We're proud that MiXCR enabled comprehensive TCR repertoire profiling in this study.
Developing a multimodal framework, new research from @bcmhouston.bsky.social reveals that a T cell's location within a tumor is a major factor influencing its function.
We're proud that MiXCR enabled comprehensive TCR repertoire profiling in this study.
September 18, 2025 at 9:20 AM
Location, location, location.
Developing a multimodal framework, new research from @bcmhouston.bsky.social reveals that a T cell's location within a tumor is a major factor influencing its function.
We're proud that MiXCR enabled comprehensive TCR repertoire profiling in this study.
Developing a multimodal framework, new research from @bcmhouston.bsky.social reveals that a T cell's location within a tumor is a major factor influencing its function.
We're proud that MiXCR enabled comprehensive TCR repertoire profiling in this study.
Prioritizing antibody candidates shouldn’t require coding bioinformatics expertise. With Platforma, biologists in academia or pharma can analyze NGS data independently, explore motifs, predict liabilities, and select the best antibody leads with confidence.
#antibody #bcr #bioinformatics
#antibody #bcr #bioinformatics
September 17, 2025 at 2:18 PM
Prioritizing antibody candidates shouldn’t require coding bioinformatics expertise. With Platforma, biologists in academia or pharma can analyze NGS data independently, explore motifs, predict liabilities, and select the best antibody leads with confidence.
#antibody #bcr #bioinformatics
#antibody #bcr #bioinformatics
For the first time, CLL's immune dysfunction has been mapped at single-cell resolution. A new @nature.com study reveals galectin-9 is a key driver of T-cell exhaustion and linked to worse outcomes.
Using MiXCR, scientists reconstructed TCR repertoires to uncover these dynamics
#CLL #TCell #TCR
Using MiXCR, scientists reconstructed TCR repertoires to uncover these dynamics
#CLL #TCell #TCR
September 4, 2025 at 12:05 PM
For the first time, CLL's immune dysfunction has been mapped at single-cell resolution. A new @nature.com study reveals galectin-9 is a key driver of T-cell exhaustion and linked to worse outcomes.
Using MiXCR, scientists reconstructed TCR repertoires to uncover these dynamics
#CLL #TCell #TCR
Using MiXCR, scientists reconstructed TCR repertoires to uncover these dynamics
#CLL #TCell #TCR
🦠 Could Epstein–Barr virus (EBV) be a hidden driver of chronic liver disease?
A new Nature Medicine study shows EBV may play a major role in primary sclerosing cholangitis (PSC).
🧵 Key findings ⬇️
A new Nature Medicine study shows EBV may play a major role in primary sclerosing cholangitis (PSC).
🧵 Key findings ⬇️
August 28, 2025 at 1:09 PM
🦠 Could Epstein–Barr virus (EBV) be a hidden driver of chronic liver disease?
A new Nature Medicine study shows EBV may play a major role in primary sclerosing cholangitis (PSC).
🧵 Key findings ⬇️
A new Nature Medicine study shows EBV may play a major role in primary sclerosing cholangitis (PSC).
🧵 Key findings ⬇️
9 patients. 40 months. 0 recurrences. 💉
A new Nature study shows the power of personalized cancer vaccines. With the help of MiXCR, researchers designed vaccines targeting each patient’s tumor profile, leading to strong T cell responses.
A big step for immunotherapy in hard-to-treat cancers.
A new Nature study shows the power of personalized cancer vaccines. With the help of MiXCR, researchers designed vaccines targeting each patient’s tumor profile, leading to strong T cell responses.
A big step for immunotherapy in hard-to-treat cancers.
August 22, 2025 at 9:54 AM
9 patients. 40 months. 0 recurrences. 💉
A new Nature study shows the power of personalized cancer vaccines. With the help of MiXCR, researchers designed vaccines targeting each patient’s tumor profile, leading to strong T cell responses.
A big step for immunotherapy in hard-to-treat cancers.
A new Nature study shows the power of personalized cancer vaccines. With the help of MiXCR, researchers designed vaccines targeting each patient’s tumor profile, leading to strong T cell responses.
A big step for immunotherapy in hard-to-treat cancers.
✨ Feeling the energy at IUIS! The excitement is contagious, and we loved sharing a live demo of Platforma with so many of you today.
🚀 If you missed it, no worries — we’ll be back tomorrow at 11 AM at the Cellecta booth. Come by to see the future of immune profiling.
🚀 If you missed it, no worries — we’ll be back tomorrow at 11 AM at the Cellecta booth. Come by to see the future of immune profiling.
August 19, 2025 at 3:11 PM
✨ Feeling the energy at IUIS! The excitement is contagious, and we loved sharing a live demo of Platforma with so many of you today.
🚀 If you missed it, no worries — we’ll be back tomorrow at 11 AM at the Cellecta booth. Come by to see the future of immune profiling.
🚀 If you missed it, no worries — we’ll be back tomorrow at 11 AM at the Cellecta booth. Come by to see the future of immune profiling.
💡 Unlock immune insights in minutes, no coding required!
Join us at @iuis-online.bsky.social in Vienna for a live demo of Platforma that will change the way you work with NGS data.
📅 Aug 19 @ 15:00–15:30
📅 Aug 20 @ 11:00–11:30
📍 Booth #75
Limited spots, so don't wait to sign up: tally.so/r/w4b8er
Join us at @iuis-online.bsky.social in Vienna for a live demo of Platforma that will change the way you work with NGS data.
📅 Aug 19 @ 15:00–15:30
📅 Aug 20 @ 11:00–11:30
📍 Booth #75
Limited spots, so don't wait to sign up: tally.so/r/w4b8er
August 12, 2025 at 3:23 PM
💡 Unlock immune insights in minutes, no coding required!
Join us at @iuis-online.bsky.social in Vienna for a live demo of Platforma that will change the way you work with NGS data.
📅 Aug 19 @ 15:00–15:30
📅 Aug 20 @ 11:00–11:30
📍 Booth #75
Limited spots, so don't wait to sign up: tally.so/r/w4b8er
Join us at @iuis-online.bsky.social in Vienna for a live demo of Platforma that will change the way you work with NGS data.
📅 Aug 19 @ 15:00–15:30
📅 Aug 20 @ 11:00–11:30
📍 Booth #75
Limited spots, so don't wait to sign up: tally.so/r/w4b8er
Great news - MiXCR just got even easier to use.
You're using the exact same trusted MiXCR engine, now boosted with Platforma's GUI and powerful downstream analysis tools. And - it’s still completely free for academia.
📽️ Watch this short video and accelerate your research today: shorturl.at/dZdEp
You're using the exact same trusted MiXCR engine, now boosted with Platforma's GUI and powerful downstream analysis tools. And - it’s still completely free for academia.
📽️ Watch this short video and accelerate your research today: shorturl.at/dZdEp
August 5, 2025 at 2:34 PM
Great news - MiXCR just got even easier to use.
You're using the exact same trusted MiXCR engine, now boosted with Platforma's GUI and powerful downstream analysis tools. And - it’s still completely free for academia.
📽️ Watch this short video and accelerate your research today: shorturl.at/dZdEp
You're using the exact same trusted MiXCR engine, now boosted with Platforma's GUI and powerful downstream analysis tools. And - it’s still completely free for academia.
📽️ Watch this short video and accelerate your research today: shorturl.at/dZdEp
🔬 New insights: A Researcher’s Guide to TCR/BCR Repertoire Analysis
Navigating the ecosystem of analysis tools can be overwhelming. We break it down - from alignment to downstream analysis.
Perfect for those working in bulk or single-cell immune repertoire profiling.
Read here: shorturl.at/8YMWA
Navigating the ecosystem of analysis tools can be overwhelming. We break it down - from alignment to downstream analysis.
Perfect for those working in bulk or single-cell immune repertoire profiling.
Read here: shorturl.at/8YMWA
July 30, 2025 at 1:35 PM
🔬 New insights: A Researcher’s Guide to TCR/BCR Repertoire Analysis
Navigating the ecosystem of analysis tools can be overwhelming. We break it down - from alignment to downstream analysis.
Perfect for those working in bulk or single-cell immune repertoire profiling.
Read here: shorturl.at/8YMWA
Navigating the ecosystem of analysis tools can be overwhelming. We break it down - from alignment to downstream analysis.
Perfect for those working in bulk or single-cell immune repertoire profiling.
Read here: shorturl.at/8YMWA
Feeling the love from the bioinformatics community ♥️ this is why we do what we do
July 23, 2025 at 4:59 PM
Feeling the love from the bioinformatics community ♥️ this is why we do what we do